nodes	percent_of_prediction	percent_of_DWPC	metapath
Flecainide—CYP2C9—Capecitabine—stomach cancer	0.0417	0.526	CbGbCtD
Flecainide—CYP2C9—Fluorouracil—stomach cancer	0.0247	0.312	CbGbCtD
Flecainide—CYP2D6—Doxorubicin—stomach cancer	0.0129	0.162	CbGbCtD
Flecainide—Jaundice—Doxorubicin—stomach cancer	0.000877	0.000952	CcSEcCtD
Flecainide—Anorexia—Docetaxel—stomach cancer	0.000876	0.000951	CcSEcCtD
Flecainide—Shock—Capecitabine—stomach cancer	0.000875	0.000951	CcSEcCtD
Flecainide—Nervous system disorder—Capecitabine—stomach cancer	0.000873	0.000948	CcSEcCtD
Flecainide—Eye disorder—Methotrexate—stomach cancer	0.000871	0.000946	CcSEcCtD
Flecainide—Diarrhoea—Fluorouracil—stomach cancer	0.000871	0.000946	CcSEcCtD
Flecainide—Thrombocytopenia—Capecitabine—stomach cancer	0.000871	0.000946	CcSEcCtD
Flecainide—Tinnitus—Methotrexate—stomach cancer	0.000869	0.000944	CcSEcCtD
Flecainide—Tachycardia—Capecitabine—stomach cancer	0.000868	0.000943	CcSEcCtD
Flecainide—Hypoaesthesia—Epirubicin—stomach cancer	0.000868	0.000943	CcSEcCtD
Flecainide—Skin disorder—Capecitabine—stomach cancer	0.000864	0.000939	CcSEcCtD
Flecainide—Hyperhidrosis—Capecitabine—stomach cancer	0.00086	0.000934	CcSEcCtD
Flecainide—Hypotension—Docetaxel—stomach cancer	0.000859	0.000933	CcSEcCtD
Flecainide—Haematuria—Doxorubicin—stomach cancer	0.000857	0.000931	CcSEcCtD
Flecainide—Anorexia—Capecitabine—stomach cancer	0.000848	0.000921	CcSEcCtD
Flecainide—Vomiting—Irinotecan—stomach cancer	0.000845	0.000918	CcSEcCtD
Flecainide—Immune system disorder—Methotrexate—stomach cancer	0.000842	0.000914	CcSEcCtD
Flecainide—Dizziness—Fluorouracil—stomach cancer	0.000842	0.000914	CcSEcCtD
Flecainide—Visual impairment—Epirubicin—stomach cancer	0.000841	0.000913	CcSEcCtD
Flecainide—Agranulocytosis—Doxorubicin—stomach cancer	0.000839	0.000911	CcSEcCtD
Flecainide—Rash—Irinotecan—stomach cancer	0.000838	0.00091	CcSEcCtD
Flecainide—Dermatitis—Irinotecan—stomach cancer	0.000837	0.000909	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000837	0.000909	CcSEcCtD
Flecainide—Headache—Irinotecan—stomach cancer	0.000833	0.000904	CcSEcCtD
Flecainide—Hypotension—Capecitabine—stomach cancer	0.000831	0.000903	CcSEcCtD
Flecainide—Insomnia—Docetaxel—stomach cancer	0.000831	0.000903	CcSEcCtD
Flecainide—Paraesthesia—Docetaxel—stomach cancer	0.000825	0.000896	CcSEcCtD
Flecainide—Alopecia—Methotrexate—stomach cancer	0.000824	0.000895	CcSEcCtD
Flecainide—Bradycardia—Doxorubicin—stomach cancer	0.000822	0.000892	CcSEcCtD
Flecainide—Dyspnoea—Docetaxel—stomach cancer	0.000819	0.00089	CcSEcCtD
Flecainide—Somnolence—Docetaxel—stomach cancer	0.000817	0.000887	CcSEcCtD
Flecainide—Eye disorder—Epirubicin—stomach cancer	0.000815	0.000885	CcSEcCtD
Flecainide—Tinnitus—Epirubicin—stomach cancer	0.000813	0.000883	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000811	0.00088	CcSEcCtD
Flecainide—Flushing—Epirubicin—stomach cancer	0.00081	0.000879	CcSEcCtD
Flecainide—Vomiting—Fluorouracil—stomach cancer	0.00081	0.000879	CcSEcCtD
Flecainide—Dyspepsia—Docetaxel—stomach cancer	0.000809	0.000878	CcSEcCtD
Flecainide—Insomnia—Capecitabine—stomach cancer	0.000805	0.000874	CcSEcCtD
Flecainide—Hypoaesthesia—Doxorubicin—stomach cancer	0.000803	0.000872	CcSEcCtD
Flecainide—Rash—Fluorouracil—stomach cancer	0.000803	0.000872	CcSEcCtD
Flecainide—Dermatitis—Fluorouracil—stomach cancer	0.000802	0.000871	CcSEcCtD
Flecainide—Paraesthesia—Capecitabine—stomach cancer	0.000799	0.000868	CcSEcCtD
Flecainide—Decreased appetite—Docetaxel—stomach cancer	0.000799	0.000868	CcSEcCtD
Flecainide—Headache—Fluorouracil—stomach cancer	0.000798	0.000866	CcSEcCtD
Flecainide—Dysgeusia—Methotrexate—stomach cancer	0.000795	0.000863	CcSEcCtD
Flecainide—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000793	0.000862	CcSEcCtD
Flecainide—Dyspnoea—Capecitabine—stomach cancer	0.000793	0.000861	CcSEcCtD
Flecainide—Fatigue—Docetaxel—stomach cancer	0.000792	0.00086	CcSEcCtD
Flecainide—Nausea—Irinotecan—stomach cancer	0.00079	0.000858	CcSEcCtD
Flecainide—Immune system disorder—Epirubicin—stomach cancer	0.000788	0.000856	CcSEcCtD
Flecainide—Pain—Docetaxel—stomach cancer	0.000786	0.000853	CcSEcCtD
Flecainide—Constipation—Docetaxel—stomach cancer	0.000786	0.000853	CcSEcCtD
Flecainide—Dyspepsia—Capecitabine—stomach cancer	0.000783	0.000851	CcSEcCtD
Flecainide—Visual impairment—Doxorubicin—stomach cancer	0.000778	0.000845	CcSEcCtD
Flecainide—Decreased appetite—Capecitabine—stomach cancer	0.000773	0.00084	CcSEcCtD
Flecainide—Alopecia—Epirubicin—stomach cancer	0.000771	0.000837	CcSEcCtD
Flecainide—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000768	0.000834	CcSEcCtD
Flecainide—Fatigue—Capecitabine—stomach cancer	0.000767	0.000833	CcSEcCtD
Flecainide—Vision blurred—Methotrexate—stomach cancer	0.000765	0.000831	CcSEcCtD
Flecainide—Pain—Capecitabine—stomach cancer	0.000761	0.000826	CcSEcCtD
Flecainide—Constipation—Capecitabine—stomach cancer	0.000761	0.000826	CcSEcCtD
Flecainide—Feeling abnormal—Docetaxel—stomach cancer	0.000757	0.000822	CcSEcCtD
Flecainide—Nausea—Fluorouracil—stomach cancer	0.000756	0.000821	CcSEcCtD
Flecainide—Eye disorder—Doxorubicin—stomach cancer	0.000754	0.000819	CcSEcCtD
Flecainide—Ill-defined disorder—Methotrexate—stomach cancer	0.000753	0.000818	CcSEcCtD
Flecainide—Tinnitus—Doxorubicin—stomach cancer	0.000753	0.000817	CcSEcCtD
Flecainide—Gastrointestinal pain—Docetaxel—stomach cancer	0.000751	0.000816	CcSEcCtD
Flecainide—Flushing—Doxorubicin—stomach cancer	0.000749	0.000814	CcSEcCtD
Flecainide—Flatulence—Epirubicin—stomach cancer	0.000748	0.000813	CcSEcCtD
Flecainide—Tension—Epirubicin—stomach cancer	0.000745	0.000809	CcSEcCtD
Flecainide—Dysgeusia—Epirubicin—stomach cancer	0.000744	0.000808	CcSEcCtD
Flecainide—Nervousness—Epirubicin—stomach cancer	0.000738	0.000801	CcSEcCtD
Flecainide—Feeling abnormal—Capecitabine—stomach cancer	0.000733	0.000796	CcSEcCtD
Flecainide—Malaise—Methotrexate—stomach cancer	0.000732	0.000795	CcSEcCtD
Flecainide—Immune system disorder—Doxorubicin—stomach cancer	0.000729	0.000792	CcSEcCtD
Flecainide—Vertigo—Methotrexate—stomach cancer	0.000729	0.000792	CcSEcCtD
Flecainide—Gastrointestinal pain—Capecitabine—stomach cancer	0.000728	0.00079	CcSEcCtD
Flecainide—Abdominal pain—Docetaxel—stomach cancer	0.000726	0.000789	CcSEcCtD
Flecainide—Body temperature increased—Docetaxel—stomach cancer	0.000726	0.000789	CcSEcCtD
Flecainide—Leukopenia—Methotrexate—stomach cancer	0.000726	0.000789	CcSEcCtD
Flecainide—Vision blurred—Epirubicin—stomach cancer	0.000716	0.000777	CcSEcCtD
Flecainide—Alopecia—Doxorubicin—stomach cancer	0.000713	0.000775	CcSEcCtD
Flecainide—Cough—Methotrexate—stomach cancer	0.000708	0.000769	CcSEcCtD
Flecainide—Urticaria—Capecitabine—stomach cancer	0.000707	0.000768	CcSEcCtD
Flecainide—Ill-defined disorder—Epirubicin—stomach cancer	0.000705	0.000765	CcSEcCtD
Flecainide—Abdominal pain—Capecitabine—stomach cancer	0.000703	0.000764	CcSEcCtD
Flecainide—Body temperature increased—Capecitabine—stomach cancer	0.000703	0.000764	CcSEcCtD
Flecainide—Convulsion—Methotrexate—stomach cancer	0.000703	0.000764	CcSEcCtD
Flecainide—Flatulence—Doxorubicin—stomach cancer	0.000692	0.000752	CcSEcCtD
Flecainide—Myalgia—Methotrexate—stomach cancer	0.000691	0.00075	CcSEcCtD
Flecainide—Arthralgia—Methotrexate—stomach cancer	0.000691	0.00075	CcSEcCtD
Flecainide—Chest pain—Methotrexate—stomach cancer	0.000691	0.00075	CcSEcCtD
Flecainide—Tension—Doxorubicin—stomach cancer	0.00069	0.000749	CcSEcCtD
Flecainide—Dysgeusia—Doxorubicin—stomach cancer	0.000688	0.000747	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000686	0.000745	CcSEcCtD
Flecainide—Malaise—Epirubicin—stomach cancer	0.000685	0.000744	CcSEcCtD
Flecainide—Discomfort—Methotrexate—stomach cancer	0.000683	0.000741	CcSEcCtD
Flecainide—Nervousness—Doxorubicin—stomach cancer	0.000683	0.000741	CcSEcCtD
Flecainide—Vertigo—Epirubicin—stomach cancer	0.000682	0.000741	CcSEcCtD
Flecainide—Syncope—Epirubicin—stomach cancer	0.000681	0.00074	CcSEcCtD
Flecainide—Leukopenia—Epirubicin—stomach cancer	0.00068	0.000738	CcSEcCtD
Flecainide—Palpitations—Epirubicin—stomach cancer	0.000671	0.000729	CcSEcCtD
Flecainide—Confusional state—Methotrexate—stomach cancer	0.000668	0.000725	CcSEcCtD
Flecainide—Loss of consciousness—Epirubicin—stomach cancer	0.000668	0.000725	CcSEcCtD
Flecainide—Cough—Epirubicin—stomach cancer	0.000663	0.00072	CcSEcCtD
Flecainide—Vision blurred—Doxorubicin—stomach cancer	0.000662	0.000719	CcSEcCtD
Flecainide—Asthenia—Docetaxel—stomach cancer	0.000659	0.000716	CcSEcCtD
Flecainide—Convulsion—Epirubicin—stomach cancer	0.000658	0.000715	CcSEcCtD
Flecainide—Hypertension—Epirubicin—stomach cancer	0.000656	0.000712	CcSEcCtD
Flecainide—Ill-defined disorder—Doxorubicin—stomach cancer	0.000652	0.000708	CcSEcCtD
Flecainide—Pruritus—Docetaxel—stomach cancer	0.00065	0.000706	CcSEcCtD
Flecainide—Nervous system disorder—Methotrexate—stomach cancer	0.00065	0.000705	CcSEcCtD
Flecainide—Thrombocytopenia—Methotrexate—stomach cancer	0.000648	0.000704	CcSEcCtD
Flecainide—Arthralgia—Epirubicin—stomach cancer	0.000647	0.000702	CcSEcCtD
Flecainide—Chest pain—Epirubicin—stomach cancer	0.000647	0.000702	CcSEcCtD
Flecainide—Myalgia—Epirubicin—stomach cancer	0.000647	0.000702	CcSEcCtD
Flecainide—Anxiety—Epirubicin—stomach cancer	0.000644	0.0007	CcSEcCtD
Flecainide—Skin disorder—Methotrexate—stomach cancer	0.000643	0.000699	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000642	0.000697	CcSEcCtD
Flecainide—Hyperhidrosis—Methotrexate—stomach cancer	0.00064	0.000695	CcSEcCtD
Flecainide—Discomfort—Epirubicin—stomach cancer	0.000639	0.000694	CcSEcCtD
Flecainide—Asthenia—Capecitabine—stomach cancer	0.000638	0.000693	CcSEcCtD
Flecainide—Malaise—Doxorubicin—stomach cancer	0.000634	0.000688	CcSEcCtD
Flecainide—Dry mouth—Epirubicin—stomach cancer	0.000632	0.000687	CcSEcCtD
Flecainide—Vertigo—Doxorubicin—stomach cancer	0.000631	0.000686	CcSEcCtD
Flecainide—Anorexia—Methotrexate—stomach cancer	0.000631	0.000686	CcSEcCtD
Flecainide—Syncope—Doxorubicin—stomach cancer	0.00063	0.000684	CcSEcCtD
Flecainide—Pruritus—Capecitabine—stomach cancer	0.000629	0.000684	CcSEcCtD
Flecainide—Leukopenia—Doxorubicin—stomach cancer	0.000629	0.000683	CcSEcCtD
Flecainide—Diarrhoea—Docetaxel—stomach cancer	0.000629	0.000683	CcSEcCtD
Flecainide—Confusional state—Epirubicin—stomach cancer	0.000625	0.000679	CcSEcCtD
Flecainide—Palpitations—Doxorubicin—stomach cancer	0.000621	0.000674	CcSEcCtD
Flecainide—Oedema—Epirubicin—stomach cancer	0.00062	0.000673	CcSEcCtD
Flecainide—Hypotension—Methotrexate—stomach cancer	0.000619	0.000672	CcSEcCtD
Flecainide—Loss of consciousness—Doxorubicin—stomach cancer	0.000618	0.000671	CcSEcCtD
Flecainide—Cough—Doxorubicin—stomach cancer	0.000613	0.000666	CcSEcCtD
Flecainide—Shock—Epirubicin—stomach cancer	0.00061	0.000662	CcSEcCtD
Flecainide—Convulsion—Doxorubicin—stomach cancer	0.000609	0.000661	CcSEcCtD
Flecainide—Diarrhoea—Capecitabine—stomach cancer	0.000609	0.000661	CcSEcCtD
Flecainide—Nervous system disorder—Epirubicin—stomach cancer	0.000608	0.00066	CcSEcCtD
Flecainide—Dizziness—Docetaxel—stomach cancer	0.000608	0.00066	CcSEcCtD
Flecainide—Thrombocytopenia—Epirubicin—stomach cancer	0.000607	0.000659	CcSEcCtD
Flecainide—Hypertension—Doxorubicin—stomach cancer	0.000607	0.000659	CcSEcCtD
Flecainide—Tachycardia—Epirubicin—stomach cancer	0.000605	0.000657	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000603	0.000655	CcSEcCtD
Flecainide—Skin disorder—Epirubicin—stomach cancer	0.000602	0.000654	CcSEcCtD
Flecainide—Hyperhidrosis—Epirubicin—stomach cancer	0.000599	0.000651	CcSEcCtD
Flecainide—Insomnia—Methotrexate—stomach cancer	0.000599	0.000651	CcSEcCtD
Flecainide—Chest pain—Doxorubicin—stomach cancer	0.000598	0.00065	CcSEcCtD
Flecainide—Myalgia—Doxorubicin—stomach cancer	0.000598	0.00065	CcSEcCtD
Flecainide—Arthralgia—Doxorubicin—stomach cancer	0.000598	0.00065	CcSEcCtD
Flecainide—Anxiety—Doxorubicin—stomach cancer	0.000596	0.000647	CcSEcCtD
Flecainide—Paraesthesia—Methotrexate—stomach cancer	0.000595	0.000646	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000594	0.000645	CcSEcCtD
Flecainide—Discomfort—Doxorubicin—stomach cancer	0.000591	0.000642	CcSEcCtD
Flecainide—Anorexia—Epirubicin—stomach cancer	0.000591	0.000642	CcSEcCtD
Flecainide—Dyspnoea—Methotrexate—stomach cancer	0.00059	0.000641	CcSEcCtD
Flecainide—Somnolence—Methotrexate—stomach cancer	0.000589	0.000639	CcSEcCtD
Flecainide—Dizziness—Capecitabine—stomach cancer	0.000588	0.000639	CcSEcCtD
Flecainide—Dry mouth—Doxorubicin—stomach cancer	0.000585	0.000635	CcSEcCtD
Flecainide—Vomiting—Docetaxel—stomach cancer	0.000584	0.000635	CcSEcCtD
Flecainide—Dyspepsia—Methotrexate—stomach cancer	0.000583	0.000633	CcSEcCtD
Flecainide—Rash—Docetaxel—stomach cancer	0.000579	0.000629	CcSEcCtD
Flecainide—Hypotension—Epirubicin—stomach cancer	0.000579	0.000629	CcSEcCtD
Flecainide—Dermatitis—Docetaxel—stomach cancer	0.000579	0.000629	CcSEcCtD
Flecainide—Confusional state—Doxorubicin—stomach cancer	0.000578	0.000628	CcSEcCtD
Flecainide—Decreased appetite—Methotrexate—stomach cancer	0.000576	0.000625	CcSEcCtD
Flecainide—Headache—Docetaxel—stomach cancer	0.000576	0.000625	CcSEcCtD
Flecainide—Oedema—Doxorubicin—stomach cancer	0.000574	0.000623	CcSEcCtD
Flecainide—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000572	0.000621	CcSEcCtD
Flecainide—Fatigue—Methotrexate—stomach cancer	0.000571	0.00062	CcSEcCtD
Flecainide—Pain—Methotrexate—stomach cancer	0.000566	0.000615	CcSEcCtD
Flecainide—Vomiting—Capecitabine—stomach cancer	0.000566	0.000614	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000565	0.000613	CcSEcCtD
Flecainide—Shock—Doxorubicin—stomach cancer	0.000564	0.000613	CcSEcCtD
Flecainide—Nervous system disorder—Doxorubicin—stomach cancer	0.000562	0.000611	CcSEcCtD
Flecainide—Thrombocytopenia—Doxorubicin—stomach cancer	0.000562	0.00061	CcSEcCtD
Flecainide—Rash—Capecitabine—stomach cancer	0.000561	0.000609	CcSEcCtD
Flecainide—Insomnia—Epirubicin—stomach cancer	0.000561	0.000609	CcSEcCtD
Flecainide—Dermatitis—Capecitabine—stomach cancer	0.00056	0.000609	CcSEcCtD
Flecainide—Tachycardia—Doxorubicin—stomach cancer	0.00056	0.000608	CcSEcCtD
Flecainide—Headache—Capecitabine—stomach cancer	0.000557	0.000605	CcSEcCtD
Flecainide—Skin disorder—Doxorubicin—stomach cancer	0.000557	0.000605	CcSEcCtD
Flecainide—Paraesthesia—Epirubicin—stomach cancer	0.000557	0.000604	CcSEcCtD
Flecainide—Hyperhidrosis—Doxorubicin—stomach cancer	0.000554	0.000602	CcSEcCtD
Flecainide—Dyspnoea—Epirubicin—stomach cancer	0.000553	0.0006	CcSEcCtD
Flecainide—Somnolence—Epirubicin—stomach cancer	0.000551	0.000598	CcSEcCtD
Flecainide—Anorexia—Doxorubicin—stomach cancer	0.000547	0.000594	CcSEcCtD
Flecainide—Nausea—Docetaxel—stomach cancer	0.000546	0.000593	CcSEcCtD
Flecainide—Feeling abnormal—Methotrexate—stomach cancer	0.000546	0.000593	CcSEcCtD
Flecainide—Dyspepsia—Epirubicin—stomach cancer	0.000546	0.000593	CcSEcCtD
Flecainide—Gastrointestinal pain—Methotrexate—stomach cancer	0.000542	0.000588	CcSEcCtD
Flecainide—Decreased appetite—Epirubicin—stomach cancer	0.000539	0.000585	CcSEcCtD
Flecainide—Hypotension—Doxorubicin—stomach cancer	0.000536	0.000582	CcSEcCtD
Flecainide—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000535	0.000581	CcSEcCtD
Flecainide—Fatigue—Epirubicin—stomach cancer	0.000534	0.00058	CcSEcCtD
Flecainide—Pain—Epirubicin—stomach cancer	0.00053	0.000576	CcSEcCtD
Flecainide—Constipation—Epirubicin—stomach cancer	0.00053	0.000576	CcSEcCtD
Flecainide—Nausea—Capecitabine—stomach cancer	0.000528	0.000574	CcSEcCtD
Flecainide—Urticaria—Methotrexate—stomach cancer	0.000526	0.000571	CcSEcCtD
Flecainide—Body temperature increased—Methotrexate—stomach cancer	0.000524	0.000569	CcSEcCtD
Flecainide—Abdominal pain—Methotrexate—stomach cancer	0.000524	0.000569	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000523	0.000567	CcSEcCtD
Flecainide—Insomnia—Doxorubicin—stomach cancer	0.000519	0.000563	CcSEcCtD
Flecainide—Paraesthesia—Doxorubicin—stomach cancer	0.000515	0.000559	CcSEcCtD
Flecainide—Dyspnoea—Doxorubicin—stomach cancer	0.000511	0.000555	CcSEcCtD
Flecainide—Feeling abnormal—Epirubicin—stomach cancer	0.000511	0.000555	CcSEcCtD
Flecainide—Somnolence—Doxorubicin—stomach cancer	0.00051	0.000554	CcSEcCtD
Flecainide—Gastrointestinal pain—Epirubicin—stomach cancer	0.000507	0.00055	CcSEcCtD
Flecainide—Dyspepsia—Doxorubicin—stomach cancer	0.000505	0.000548	CcSEcCtD
Flecainide—Decreased appetite—Doxorubicin—stomach cancer	0.000499	0.000541	CcSEcCtD
Flecainide—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000495	0.000538	CcSEcCtD
Flecainide—Fatigue—Doxorubicin—stomach cancer	0.000494	0.000537	CcSEcCtD
Flecainide—Urticaria—Epirubicin—stomach cancer	0.000492	0.000535	CcSEcCtD
Flecainide—Pain—Doxorubicin—stomach cancer	0.00049	0.000533	CcSEcCtD
Flecainide—Constipation—Doxorubicin—stomach cancer	0.00049	0.000533	CcSEcCtD
Flecainide—Body temperature increased—Epirubicin—stomach cancer	0.00049	0.000532	CcSEcCtD
Flecainide—Abdominal pain—Epirubicin—stomach cancer	0.00049	0.000532	CcSEcCtD
Flecainide—Asthenia—Methotrexate—stomach cancer	0.000475	0.000516	CcSEcCtD
Flecainide—Feeling abnormal—Doxorubicin—stomach cancer	0.000473	0.000513	CcSEcCtD
Flecainide—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000469	0.000509	CcSEcCtD
Flecainide—Pruritus—Methotrexate—stomach cancer	0.000469	0.000509	CcSEcCtD
Flecainide—Urticaria—Doxorubicin—stomach cancer	0.000456	0.000495	CcSEcCtD
Flecainide—Abdominal pain—Doxorubicin—stomach cancer	0.000453	0.000492	CcSEcCtD
Flecainide—Body temperature increased—Doxorubicin—stomach cancer	0.000453	0.000492	CcSEcCtD
Flecainide—Diarrhoea—Methotrexate—stomach cancer	0.000453	0.000492	CcSEcCtD
Flecainide—Asthenia—Epirubicin—stomach cancer	0.000445	0.000483	CcSEcCtD
Flecainide—Pruritus—Epirubicin—stomach cancer	0.000439	0.000476	CcSEcCtD
Flecainide—Dizziness—Methotrexate—stomach cancer	0.000438	0.000476	CcSEcCtD
Flecainide—Diarrhoea—Epirubicin—stomach cancer	0.000424	0.000461	CcSEcCtD
Flecainide—Vomiting—Methotrexate—stomach cancer	0.000421	0.000457	CcSEcCtD
Flecainide—Rash—Methotrexate—stomach cancer	0.000418	0.000454	CcSEcCtD
Flecainide—Dermatitis—Methotrexate—stomach cancer	0.000417	0.000453	CcSEcCtD
Flecainide—Headache—Methotrexate—stomach cancer	0.000415	0.000451	CcSEcCtD
Flecainide—Asthenia—Doxorubicin—stomach cancer	0.000411	0.000447	CcSEcCtD
Flecainide—Dizziness—Epirubicin—stomach cancer	0.00041	0.000445	CcSEcCtD
Flecainide—Pruritus—Doxorubicin—stomach cancer	0.000406	0.000441	CcSEcCtD
Flecainide—Vomiting—Epirubicin—stomach cancer	0.000394	0.000428	CcSEcCtD
Flecainide—Nausea—Methotrexate—stomach cancer	0.000393	0.000427	CcSEcCtD
Flecainide—Diarrhoea—Doxorubicin—stomach cancer	0.000392	0.000426	CcSEcCtD
Flecainide—Rash—Epirubicin—stomach cancer	0.000391	0.000424	CcSEcCtD
Flecainide—Dermatitis—Epirubicin—stomach cancer	0.00039	0.000424	CcSEcCtD
Flecainide—Headache—Epirubicin—stomach cancer	0.000388	0.000422	CcSEcCtD
Flecainide—Dizziness—Doxorubicin—stomach cancer	0.000379	0.000412	CcSEcCtD
Flecainide—Nausea—Epirubicin—stomach cancer	0.000368	0.0004	CcSEcCtD
Flecainide—Vomiting—Doxorubicin—stomach cancer	0.000365	0.000396	CcSEcCtD
Flecainide—Rash—Doxorubicin—stomach cancer	0.000362	0.000393	CcSEcCtD
Flecainide—Dermatitis—Doxorubicin—stomach cancer	0.000361	0.000392	CcSEcCtD
Flecainide—Headache—Doxorubicin—stomach cancer	0.000359	0.00039	CcSEcCtD
Flecainide—Nausea—Doxorubicin—stomach cancer	0.000341	0.00037	CcSEcCtD
